Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia

This study is currently recruiting participants.

Study NCT00217646 Information provided by National Cancer Institute (NCI)

First Received: September 20, 2005 Last Updated: June 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2006 (Final data collection date for primary outcome measure)